tetano
Editor, Senior Moderator
Expert Rev Vaccines
. 2022 Aug 30.
doi: 10.1080/14760584.2022.2117693. Online ahead of print.
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
Kyu-Bin Oh[SUP] 1 [/SUP], T Mark Doherty[SUP] 2 [/SUP], Volker Vetter[SUP] 3 [/SUP], Paolo Bonanni[SUP] 4 [/SUP]
Affiliations
Abstract
Introduction: In the first months of the novel coronavirus (COVID-19) pandemic that begun in 2020, non-pharmaceutical interventions (NPIs) have been adopted worldwide. However, the effects of NPI implementation go beyond slowing the spread of COVID-19. Here, we review the non-intended effects that may have arisen from prolonged application of NPIs.
Areas covered: NPIs also affected the epidemiology of other infectious diseases, with unprecedentedly low circulation of several respiratory and gastrointestinal viruses being observed worldwide in 2020. While this was a welcome effect for already strained healthcare systems, prolonged low exposure to pathogens may result in an increased pool of individuals susceptible to certain diseases. Out-of-season or unusually intense outbreaks of non-vaccine preventable diseases have already been documented as NPIs were gradually eased. In the context of widespread and important disruptions in national vaccination programs during the early phase of the pandemic, the risk of vaccine-preventable disease resurgence after NPIs are lifted cannot be excluded either.
Expert opinion: Awareness must be raised of the risk of vaccine-preventable disease resurgence, and efforts need to be made to mitigate this risk, where possible, by increasing vaccination coverage. Research and regulatory opportunities brought on by the COVID-19 pandemic should be seized.
Keywords: COVID-19 pandemic; infectious diseases; influenza; non-pharmaceutical interventions; norovirus; outbreaks; respiratory syncytial virus; resurgence; rhinovirus; vaccine-preventable diseases.
. 2022 Aug 30.
doi: 10.1080/14760584.2022.2117693. Online ahead of print.
Lifting non-pharmaceutical interventions following the COVID-19 pandemic - the quiet before the storm?
Kyu-Bin Oh[SUP] 1 [/SUP], T Mark Doherty[SUP] 2 [/SUP], Volker Vetter[SUP] 3 [/SUP], Paolo Bonanni[SUP] 4 [/SUP]
Affiliations
- PMID: 36039786
- DOI: 10.1080/14760584.2022.2117693
Abstract
Introduction: In the first months of the novel coronavirus (COVID-19) pandemic that begun in 2020, non-pharmaceutical interventions (NPIs) have been adopted worldwide. However, the effects of NPI implementation go beyond slowing the spread of COVID-19. Here, we review the non-intended effects that may have arisen from prolonged application of NPIs.
Areas covered: NPIs also affected the epidemiology of other infectious diseases, with unprecedentedly low circulation of several respiratory and gastrointestinal viruses being observed worldwide in 2020. While this was a welcome effect for already strained healthcare systems, prolonged low exposure to pathogens may result in an increased pool of individuals susceptible to certain diseases. Out-of-season or unusually intense outbreaks of non-vaccine preventable diseases have already been documented as NPIs were gradually eased. In the context of widespread and important disruptions in national vaccination programs during the early phase of the pandemic, the risk of vaccine-preventable disease resurgence after NPIs are lifted cannot be excluded either.
Expert opinion: Awareness must be raised of the risk of vaccine-preventable disease resurgence, and efforts need to be made to mitigate this risk, where possible, by increasing vaccination coverage. Research and regulatory opportunities brought on by the COVID-19 pandemic should be seized.
Keywords: COVID-19 pandemic; infectious diseases; influenza; non-pharmaceutical interventions; norovirus; outbreaks; respiratory syncytial virus; resurgence; rhinovirus; vaccine-preventable diseases.